J0665 HCPCS code: Injection, bupivicaine, not otherwise specified, 0.5 mg
J0665 is the HCPCS Level II code for injection, bupivicaine, not otherwise specified, 0.5 mg. In 2024 Medicare paid an average of $0.01 per service for J0665 across 2,668,741 services. Its Medicare coverage code is C (Carrier judgment): Coverage is decided by the Medicare contractor (MAC) case by case. Medicare volume rose 471% from 2023 to 2024 (467,391 to 2,668,741 services). In 2024, about 2,775 clinicians billed Medicare for J0665 for 45,464 beneficiaries; California, New Jersey, North Carolina accounted for 38% of services.
Code details
| Field | Value |
|---|---|
| Section | J codes — Drugs administered other than oral method |
| Coverage code | C — Carrier judgment |
| Pricing indicator | 51 — Drug or biological (priced per ASP/average sales price rules) |
| BETOS category | O1E — Other drugs |
| Added | 2023-07-01 |
| Last action effective | 2024-01-01 |
Who bills J0665 (2024)
| Measure | Value |
|---|---|
| Clinicians billing (by place of service) | 2,775 |
| Medicare beneficiaries | 45,464 |
| States with claims | 51 |
| Share of services in top 3 states (California, New Jersey, North Carolina) | 38% |
Counts only. Supplier and clinician names, contact lists and state-by-state detail are in Caduvo.
Medicare utilization for J0665, 2023–2024
| Year | Services | Beneficiaries | Avg. allowed | Avg. paid |
|---|---|---|---|---|
| 2023 | 467,391 | 14,857 | $0.02 | $0.01 |
| 2024 | 2,668,741 | 45,464 | $0.01 | $0.01 |
States with the most J0665 services (2024)
| State | Services | Avg. paid |
|---|---|---|
| California | 623,751 | $0.01 |
| New Jersey | 194,525 | $0.01 |
| North Carolina | 191,447 | $0.01 |
| Texas | 188,096 | $0.01 |
| Washington | 158,206 | $0.01 |
What changed for J0665
- 2023-07-01: J0665 added to HCPCS Level II
- Next scheduled CMS quarterly update (HCPCS and DMEPOS fee schedule): 2027-01-01
Frequently asked questions
What is HCPCS code J0665?
J0665 is the HCPCS Level II code for injection, bupivicaine, not otherwise specified, 0.5 mg. Short descriptor: "Inj, bupivacaine, nos, 0.5mg".
How much does Medicare pay for J0665?
In 2024, the average Medicare payment was $0.01 per service (average allowed $0.01).
Does Medicare cover J0665?
Coverage code C — Carrier judgment. Coverage is decided by the Medicare contractor (MAC) case by case.
Related J06 codes
- J0600 — Injection, edetate calcium disodium, up to 1000 mg
- J0601 — Sevelamer carbonate (renvela or therapeutically equivalent), oral, 20 mg (for esrd on dialysis)
- J0602 — Sevelamer carbonate (renvela or therapeutically equivalent), oral, powder, 20 mg (for esrd on dialysis)
- J0603 — Sevelamer hydrochloride (renagel or therapeutically equivalent), oral, 20 mg (for esrd on dialysis)
- J0604 — Cinacalcet, oral, 1 mg, (for esrd on dialysis)
- J0605 — Sucroferric oxyhydroxide, oral, 5 mg (for esrd on dialysis)
- J0606 — Injection, etelcalcetide, 0.1 mg
- J0607 — Lanthanum carbonate, oral, 5 mg (for esrd on dialysis)
- J0608 — Lanthanum carbonate, oral, powder, 5 mg, not therapeutically equivalent to j0607 (for esrd on dialysis)
- J0609 — Ferric citrate, oral, 3 mg ferric iron, (for esrd on dialysis)
- J0610 — Injection, calcium gluconate (fresenius kabi), per 10 ml
- J0611 — Injection, calcium gluconate (wg critical care), per 10 ml
Building a device that would bill under a code like this? Caduvo matches a device description to HCPCS/CPT codes, Medicare coverage and payment, and the FDA pathway in one report.
Next steps
- Run a reimbursement report for a device billed under J0665
- Watch J0665 for fee, coverage and descriptor changes
- Build a full Medicare revenue model for J0665
Sources: CMS HCPCS Level II release October 2026; CMS DMEPOS fee schedule; CMS NCCI MUE tables; CMS Medicare utilization (physician and DME supplier files); CMS Medicare Coverage Database articles. Fees are Medicare allowables, not commercial rates. Not billing or legal advice.